These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2752182)

  • 1. Phase II evaluation of mitoxantrone in advanced non anaplastic thyroid cancer.
    Schlumberger M; Parmentier C
    Bull Cancer; 1989; 76(4):403-6. PubMed ID: 2752182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial.
    Williams SD; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Mar; 70(3):405-7. PubMed ID: 3955552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of mitoxantrone in epithelial ovarian cancer.
    Lawton F; Blackledge G; Mould J; Latief T; Watson R; Chetiyawardana AD
    Cancer Treat Rep; 1987 Jun; 71(6):627-9. PubMed ID: 3581101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II clinical trial on mitoxantrone].
    Gao HR
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):204-6. PubMed ID: 2693025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
    Muss HB; Bundy BN; DiSaia PJ; Ehrlich CE
    Cancer Treat Rep; 1987 Feb; 71(2):217-8. PubMed ID: 3802120
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy of metastatic thyroid cancer. Phase II study.
    Bukowski RM; Brown L; Weick JK; Groppe CW; Purvis J
    Am J Clin Oncol; 1983 Oct; 6(5):579-81. PubMed ID: 6193705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone in elderly women with advanced breast cancer: a phase II study.
    Repetto L; Simoni C; Venturino A; Biancardi V; Gasco M; Campora E; Rosso R
    Anticancer Res; 1995; 15(5B):2297-300. PubMed ID: 8572641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.
    Alberts DS; Surwit EA; Peng YM; McCloskey T; Rivest R; Graham V; McDonald L; Roe D
    Cancer Res; 1988 Oct; 48(20):5874-7. PubMed ID: 3167842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group.
    Panagos GE
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S17-21. PubMed ID: 9071335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
    Hørding U; Rose C; Jakobsen K; Dirksen H
    Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.
    McDonald DB; Abu-Zahra H; Yoshida S; Binder H
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):19-22. PubMed ID: 6385260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone in the treatment of patients with non-Hodgkin's Lymphoma.
    Foss-Abrahamsen A; Lenner P; Hedenus M; Landys K; Noppa H
    Cancer Treat Rep; 1987 Dec; 71(12):1209-12. PubMed ID: 3690531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.
    Osborne CK; Drelichman A; Von Hoff DD; Crawford ED
    Cancer Treat Rep; 1983 Dec; 67(12):1133-5. PubMed ID: 6652630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of mitoxantrone in advanced breast cancer.
    Pronzato P; Ardizzoni A; Conte PF; Gulisano M; Lionetto R; Repetto L; Scornavacche V; Sertoli MR; Rosso R
    Chemioterapia; 1986 Jun; 5(3):150-3. PubMed ID: 3719852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of a combination of doxorubicin and mitoxantrone in metastatic breast cancer.
    Ford JM; Panasci L; Leclerc Y; Margolese R
    Cancer Treat Rep; 1987 Oct; 71(10):921-5. PubMed ID: 3308079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.